Pain News and Research

Latest Pain News and Research

No evidence for added benefits of spinal manipulation for acute lower back pain

Manipulating or "adjusting" the spine is a popular way to treat occasional or acute lower back pain and is covered by many health insurance plans, but a recent review by The Cochrane Library finds no evidence to suggest it is more effective than other therapy options.

21 Sep 2012

Partially-matched bone marrow transplants can eliminate sickle cell disease in some patients

In a preliminary clinical trial, investigators at Johns Hopkins have shown that even partially-matched bone marrow transplants can eliminate sickle cell disease in some patients, ridding them of painful and debilitating symptoms, and the need for a lifetime of pain medications and blood transfusions. The researchers say the use of such marrow could potentially help make bone marrow transplants accessible to a majority of sickle cell patients who need them.

21 Sep 2012

Partially-matched bone marrow transplants can eliminate sickle cell disease in some patients

21 Sep 2012

Ultrasound boosts rheumatology clinical examination findings

Musculoskeletal ultrasound improves rheumatology diagnosis and guides treatment, say researchers who believe imaging should be performed alongside clinical examination.

21 Sep 2012

Bipolar patients show poor HRQoL regardless of treatment setting

Patients with bipolar disorder who present for treatment in primary care settings and those who present at community mental health clinics have equally poor health-related quality of life, US research shows.

21 Sep 2012

Same-day discharge after laparoscopic hysterectomy ‘poses no safety concerns’

Researchers say that patients undergoing laparoscopic hysterectomy can be discharged the same day, with no associated safety concerns.

21 Sep 2012

Longer looks: A 'renegade' Bill Frist?; The pharmacist's expanding role

Meet former Sen. Bill Frist, a renegade "Obamacare"-loving Republican who is in the mood for some real bipartisanship. Yes, the same Frist who as Senate majority leader led an army into the culture wars over Terri Schiavo and whose efforts in 2004 to unseat his then-rival, Minority Leader Tom Daschle, led to a nasty - and personal - Washington battle royal. Now, Frist is pushing for a national conversation on end-of-life care and dismissing "caricatured" talk of death panels.

21 Sep 2012

N.Y. Times examines why many kidneys available for transplant are discarded

In each of the past five years, more than 2,600 kidneys were recovered and discarded, according to government data.

21 Sep 2012

Study of spinal injury data may help surgeons treat injured soldiers or civilians

Spinal injuries are among the most disabling conditions affecting wounded members of the U.S. military. Yet until recently, the nature of those injuries had not been adequately explored.

21 Sep 2012

FDA approves Acton’s AEROSPAN sNDA to treat asthma

Acton Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the sNDA (Supplemental New Drug Application) for AEROSPAN (flunisolide HFA, 80 mcg) Inhalation Aerosol, a hydrofluoroalkane (HFA) orally inhaled corticosteroid indicated for the maintenance treatment of asthma as a prophylactic therapy in adult and pediatric patients 6 years of age and older.

21 Sep 2012

St. Jude Medical’s Eon family of neurostimulators receives European CE Mark approval

St. Jude Medical, Inc., a global medical device company, today announced it has received European CE Mark approval of its Eon family of neurostimulators for patients with intractable chronic migraine. Unveiled at the European Headache and Migraine Trust International Congress in London, this approval includes the Eon Mini neurostimulator, which is the world's smallest rechargeable neurostimulator with the longest-lasting battery in its class, and the Eon and EonC neurostimulators.

21 Sep 2012

Positive results from Galleon GAL-021 second Phase I study on respiratory depression

Galleon Pharmaceuticals, a leader in the development of novel medicines to treat breathing control disorders, today announced that results from a second Phase I clinical study of its investigational drug GAL-021 confirmed previous findings that the drug has dose-dependent effects on respiration.

21 Sep 2012

Hypertonic solution effective in reducing inflammation

Research carried out at The University of Manchester has found further evidence that a simple solution, which is already used in IV drips, is an effective treatment for reducing inflammation.

From The University of Manchester 21 Sep 2012

Amgen receives FDA approval for Prolia to treat bone loss in men with osteoporosis

Amgen today announced the U.S. Food and Drug Administration (FDA) approved a new indication for Prolia (denosumab) as a treatment to increase bone mass in men with osteoporosis at high risk for fracture.

21 Sep 2012

Boehringer Ingelheim files MAA with EMA for afatinib approval

Today, Boehringer Ingelheim has announced the submission of a Marketing Authorisation Application to the European Medicines Agency (EMA) for approval of afatinib, the first irreversible ErbB Family Blocker, as a treatment for patients with EGFR (ErbB1) mutation positive non-small cell lung cancer (NSCLC). Afatinib has demonstrated unprecedented efficacy versus chemotherapy in the Phase III LUX-Lung 3 registration trial, which provides pivotal support for this submission.

20 Sep 2012

Many children with ASD also experience anxiety, GI problems and atypical sensory responses

One in 88 children has been diagnosed with an autism spectrum disorder (ASD) in the United States, according to the Centers for Disease Control and Prevention. A new study by a University of Missouri researcher found that many children with ASD also experience anxiety, chronic gastrointestinal (GI) problems and atypical sensory responses, which are heightened reactions to light, sound or particular textures.

20 Sep 2012

Hip implants are more likely to fail in obese people due to thigh size

University of Iowa researchers have determined that thigh size in obese people is a reason their hip implants are more likely to fail.

20 Sep 2012

Endothelial colony-forming cells show promise against inflammatory bowel disease

New research shows that a special population of stem cells found in cord blood has the innate ability to migrate to the intestine and contribute to the cell population there, suggesting the cells' potential to treat inflammatory bowel disease (IBD).

20 Sep 2012

Oral contraceptive use can lead to increased pain during intercourse among young women

According to the Guttmacher Institute, over ten million women in the US use oral contraceptives. Although birth control pills are an effective way to prevent pregnancy, keep acne at bay, and treat menstrual pain or irregularity, there may be some health concerns that are undisclosed to patients. A recent study suggests that oral contraceptive use can lead to increased pain during intercourse, with decreased libido and spontaneous arousability as well as diminished frequency of sexual intercourse and orgasm in young women.

19 Sep 2012

Inhaled pain relief effective in first labor stage

A Cochrane review shows that inhaled pain relief is more effective than no pain relief at all in reducing pain intensity during the first stage of labor, say researchers.

19 Sep 2012

Pain News and Research

Latest Pain News and Research

No evidence for added benefits of spinal manipulation for acute lower back pain

Partially-matched bone marrow transplants can eliminate sickle cell disease in some patients

Partially-matched bone marrow transplants can eliminate sickle cell disease in some patients

Ultrasound boosts rheumatology clinical examination findings

Bipolar patients show poor HRQoL regardless of treatment setting

Same-day discharge after laparoscopic hysterectomy ‘poses no safety concerns’

Longer looks: A 'renegade' Bill Frist?; The pharmacist's expanding role

N.Y. Times examines why many kidneys available for transplant are discarded

Study of spinal injury data may help surgeons treat injured soldiers or civilians

FDA approves Acton’s AEROSPAN sNDA to treat asthma

St. Jude Medical’s Eon family of neurostimulators receives European CE Mark approval

Positive results from Galleon GAL-021 second Phase I study on respiratory depression

Hypertonic solution effective in reducing inflammation

Amgen receives FDA approval for Prolia to treat bone loss in men with osteoporosis

Boehringer Ingelheim files MAA with EMA for afatinib approval

Many children with ASD also experience anxiety, GI problems and atypical sensory responses

Hip implants are more likely to fail in obese people due to thigh size

Endothelial colony-forming cells show promise against inflammatory bowel disease

Oral contraceptive use can lead to increased pain during intercourse among young women

Inhaled pain relief effective in first labor stage

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Pain News and Research

Latest Pain News and Research

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Newsletters you may be interested in